Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Feith

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Cancer Biology & Therapy|August 8, 2015
Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemiaFrancis R LeBlanc, Xin Liu, Jeremy Hengst, et al.
British Journal of Haematology|March 4, 2020
Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1Francis R LeBlanc, Jennifer M Pearson, Su-Fern Tan, et al.
British Journal of Haematology|October 15, 2019
Retroviral sero-reactivity in LGL leukaemia patients and family membersSusan B Nyland, David J Feith, Mary Poss, et al.
Molecular Cancer Therapeutics|July 9, 2009
Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastomaDana-Lynn T Koomoa, Tamas Borsics, David J Feith, et al.
BMC Medical Genomics|June 19, 2019
Retrovirus insertion site analysis of LGL leukemia patient genomesWeiling Li, Lei Yang, Robert S Harris, et al.
Cytokine|November 21, 2018
Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytesKristine C Olson, Paige M Kulling Larkin, Rossana Signorelli, et al.
International Journal of Cancer|December 5, 2009
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationDirk Geerts, Jan Koster, David Albert, et al.
The Journal of Clinical Investigation|April 7, 2004
Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- miceXiuwei Tang, Arianna L Kim, David J Feith, et al.
Biochimica Et Biophysica Acta|March 15, 2015
Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxicsSamy A F Morad, Su-Fern Tan, David J Feith, et al.
Best Practice & Research. Clinical Haematology|October 6, 2019
Genomics of LGL leukemia and select other rare leukemia/lymphomasKatharine B Moosic, Umadevi Paila, Kristine C Olson, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Cancer Biology & Therapy|August 8, 2015
Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemiaFrancis R LeBlanc, Xin Liu, Jeremy Hengst, et al.
British Journal of Haematology|March 4, 2020
Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1Francis R LeBlanc, Jennifer M Pearson, Su-Fern Tan, et al.
British Journal of Haematology|October 15, 2019
Retroviral sero-reactivity in LGL leukaemia patients and family membersSusan B Nyland, David J Feith, Mary Poss, et al.
Molecular Cancer Therapeutics|July 9, 2009
Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastomaDana-Lynn T Koomoa, Tamas Borsics, David J Feith, et al.
BMC Medical Genomics|June 19, 2019
Retrovirus insertion site analysis of LGL leukemia patient genomesWeiling Li, Lei Yang, Robert S Harris, et al.
Cytokine|November 21, 2018
Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytesKristine C Olson, Paige M Kulling Larkin, Rossana Signorelli, et al.
International Journal of Cancer|December 5, 2009
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationDirk Geerts, Jan Koster, David Albert, et al.
The Journal of Clinical Investigation|April 7, 2004
Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- miceXiuwei Tang, Arianna L Kim, David J Feith, et al.
Biochimica Et Biophysica Acta|March 15, 2015
Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxicsSamy A F Morad, Su-Fern Tan, David J Feith, et al.
Best Practice & Research. Clinical Haematology|October 6, 2019
Genomics of LGL leukemia and select other rare leukemia/lymphomasKatharine B Moosic, Umadevi Paila, Kristine C Olson, et al.
Pageof 8